LivaNova Reports First-Quarter 2026 Results
LivaNova PLC announced its first-quarter results for 2026, reporting a revenue of $362.3 million, which is a 14.3% increase on a reported basis compared to the previous year. The company also raised its full-year guidance for revenue and adjusted diluted EPS.
LONDON–(BUSINESS WIRE)—- $LIVN #OSA–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2026 and raised full-year 2026 guidance. Financial Summary and Highlights(1) First-quarter revenue of $362.3 million increased 14.3% on a reported basis and 11.1% on a constant-currency basis as compared to the prior-year period First-quarter U.S. GAAP diluted earnings per share of $0.40 and adjusted diluted earnings per share of $0.98 F